Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Shandong Weigao Group Medical Polymer Co's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $3,076 Mil. Shandong Weigao Group Medical Polymer Co's Total Assets for the quarter that ended in Jun. 2023 was $4,739 Mil.
Therefore, Shandong Weigao Group Medical Polymer Co's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.65.
The historical rank and industry rank for Shandong Weigao Group Medical Polymer Co's Equity-to-Asset or its related term are showing as below:
SHWGY'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.61 Med: 0.66 Max: 0.82
Current: 0.67
During the past 13 years, the highest Equity to Asset Ratio of Shandong Weigao Group Medical Polymer Co was 0.82. The lowest was 0.61. And the median was 0.66.
SHWGY's Equity-to-Asset is ranked better than 53.45% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs SHWGY: 0.67
Shandong Weigao Group Medical Polymer Co Equity-to-Asset Historical Data
The historical data trend for Shandong Weigao Group Medical Polymer Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shandong Weigao Group Medical Polymer Co Annual Data
For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Group Medical Polymer Co Equity-to-Asset Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Equity-to-Asset falls into.
Shandong Weigao Group Medical Polymer Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Shandong Weigao Group Medical Polymer Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Shandong Weigao Group Medical Polymer Co Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHWGY has been successfully added to your 